High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients

The use of high-dose of intravenous immunoglobulins (IVIGs) as immunomodulators for the treatment of COVID-19–affected individuals has shown promising results. IVIG reduced inflammation in these patients, who progressively restored respiratory function. However, little is known about how they may mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez de la Concepción, María Luisa, Ainsua-Enrich, Erola, Reynaga, Esteban, Ávila-Nieto, Carlos, Santos, Jose Ramón, Roure, Silvia, Mateu, Lourdes, Paredes, Roger, Puig, Jordi, Jimenez, Juan Manuel, Izquierdo-Useros, Nuria, Clotet, Bonaventura, Pedro-Botet, María Luisa, Carrillo, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321664/
https://www.ncbi.nlm.nih.gov/pubmed/34321327
http://dx.doi.org/10.26508/lsa.202001009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321664/
https://www.ncbi.nlm.nih.gov/pubmed/34321327
http://dx.doi.org/10.26508/lsa.202001009

Ejemplares similares